Combinatorial effects of double cardiomyopathy mutant alleles in rodent myocytes: A predictive cellular model of myofilament dysregulation in disease

PLoS ONE

Volumn 5, Issue 2, 2010, Pages

  Davis, Jennifer ^a   Metzger, Joseph M ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; TROPOMYOSIN; TROPONIN C; CALCIUM; TROPONIN; TROPONIN I;

ANIMAL CELL; ARTICLE; CARDIOMYOPATHY; CELL ACTIVATION; CELL ISOLATION; CONTROLLED STUDY; GENE FREQUENCY; GENE TRANSFER; HEART MUSCLE CELL; MYOFILAMENT; NONHUMAN; PROTEIN EXPRESSION; RAT; SARCOMERE; STOICHIOMETRY; WESTERN BLOTTING; ALLELE; ANIMAL; BIOLOGICAL MODEL; CELL CULTURE; CELL SIZE; CYTOLOGY; FEMALE; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; MICROFILAMENT; MUTATION; PATHOLOGY; PROTEIN BINDING; SPRAGUE DAWLEY RAT;

RATTUS; RODENTIA;

ALLELES; ANIMALS; BLOTTING, WESTERN; CALCIUM; CARDIOMYOPATHIES; CELL SIZE; CELLS, CULTURED; FEMALE; HUMANS; MICROFILAMENTS; MODELS, BIOLOGICAL; MUTATION; MYOCYTES, CARDIAC; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; TRANSFECTION; TROPOMYOSIN; TROPONIN; TROPONIN C; TROPONIN I;

EID: 77949358459     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009140     Document Type: Article

References (76)

1. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, et al. (1995) Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 92: 785-789.
2. Braunwald E, Seidman CE, Sigwart U (2002) Contemporary evaluation and management of hypertrophic cardiomyopathy. Circulation 106: 1312-1316.
3. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, et al. (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113: 1807-1816.
4. Doolan A, Nguyen L, Semsarian C (2004) Hypertrophic cardiomyopathy: from "heart tumour" to a complex molecular genetic disorder. Heart Lung Circ 13: 15-25.
5. NHLBI Program for Genomic Applications HMS (7 A.D. June) Genomics of Cardiovascular Development, Adaptation, and Remodeling. http://www. cardiogenomics.org.
6. Epstein ND (1998) The molecular biology and pathophysiology of hypertrophic cardiomyopathy due to mutations in the beta myosin heavy chains and the essential and regulatory light chains. Adv Exp Med Biol 453: 105-114.
7. Fatkin D, Graham RM (2002) Molecular mechanisms of inherited cardiomyopathies. Physiol Rev 82: 945-980.
8. Alpert NR, Mohiddin SA, Tripodi D, Jacobson-Hatzell J, Vaughn-Whitley K, et al. (2005) Molecular and phenotypic effects of heterozygous, homozygous, and compound heterozygote myosin heavy-chain mutations. Am J Physiol Heart Circ Physiol 288: H1097-H1102.
9. Ingles J, Doolan A, Chiu C, Seidman J, Seidman C, et al. (2005) Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling. J Med Genet 42: e59.
10. Mohiddin SA, Begley DA, McLam E, Cardoso JP, Winkler JB, et al. (2003) Utility of genetic screening in hypertrophic cardiomyopathy: prevalence and significance of novel and double (homozygous and heterozygous) beta-myosin mutations. Genet Test 7: 21-27.
11. Richard P, Isnard R, Carrier L, Dubourg O, Donatien Y, et al. (1999) Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy. J Med Genet 36: 542-545.
12. Richard P, Charron P, Leclercq C, Ledeuil C, Carrier L, et al. (2000) Homozygotes for a R869G mutation in the beta -myosin heavy chain gene have a severe form of familial hypertrophic cardiomyopathy. J Mol Cell Cardiol 32: 1575-1583.
13. Van Driest SL, Ackerman MJ, Ommen SR, Shakur R, Will ML, et al. (2002) Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy. Circulation 106: 3085-3090.
14. Van Driest SL, Vasile VC, Ommen SR, Will ML, Tajik AJ, et al. (2004) Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J Am Coll Cardiol 44: 1903-1910.
15. Nanni L, Pieroni M, Chimenti C, Simionati B, Zimbello R, et al. (2003) Hypertrophic cardiomyopathy: two homozygous cases with "typical" hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy. Biochem Biophys Res Commun 309: 391-398.
16. Niimura H, Bachinski LL, Sangwatanaroj S, Watkins H, Chudley AE, et al. (1998) Mutations in the gene for cardiac myosin-binding protein C and lateonset familial hypertrophic cardiomyopathy. N Engl J Med 338: 1248-1257.
17. Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, et al. (2003) Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 107: 2227-2232.
18. Ho CY, Lever HM, DeSanctis R, Farver CF, Seidman JG, et al. (2000) Homozygous mutation in cardiac troponin T: implications for hypertrophic cardiomyopathy. Circulation 102: 1950-1955.
19. Lin T, Ichihara S, Yamada Y, Nagasaka T, Ishihara H, et al. (2000) Phenotypic variation of familial hypertrophic cardiomyopathy caused by the Phe(110)->Ile mutation in cardiac troponin T. Cardiology 93: 155-162.
20. Tsoutsman T, Bagnall RD, Semsarian C (2008) Impact of multiple gene mutations in determining the severity of cardiomyopathy and heart failure. Clin Exp Pharmacol Physiol 35: 1349-1357.
21. Frazier A, Judge DP, Schulman SP, Johnson N, Holmes KW, et al. (2008) Familial hypertrophic cardiomyopathy associated with cardiac beta-myosin heavy chain and troponin I mutations. Pediatr Cardiol 29: 846-850.
22. Davis J, Wen H, Edwards T, Metzger JM (2007) Thin filament disinhibition by restrictive cardiomyopathy mutant R193H troponin I induces Ca2+-independent mechanical tone and acute myocyte remodeling. Circ Res 100: 1494-1502.
23. Geisterfer-Lowrance AA, Kass S, Tanigawa G, Vosberg HP, McKenna W, et al. (1990) A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell 62: 999-1006.
24. Harris SP, Bartley CR, Hacker TA, McDonald KS, Douglas PS, et al. (2002) Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice. Circ Res 90: 594-601.
25. Michele DE, Gomez CA, Hong KE, Westfall MV, Metzger JM (2002) Cardiac dysfunction in hypertrophic cardiomyopathy mutant tropomyosin mice is transgene-dependent, hypertrophy-independent, and improved by beta-blockade. Circ Res 91: 255-262.
26. Garcia-Castro M, Reguero JR, Alvarez V, Batalla A, Soto MI, et al. (2005) Hypertrophic cardiomyopathy linked to homozygosity for a new mutation in the myosin-binding protein C gene (A627V) suggests a dosage effect. Int J Cardiol 102: 501-507.
27. McConnell BK, Jones KA, Fatkin D, Arroyo LH, Lee RT, et al. (1999) Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice. J Clin Invest 104: 1771.
28. Tsoutsman T, Kelly M, Ng DC, Tan JE, Tu E, et al. (2008) Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy. Circulation 117: 1820-1831.
29. Davis J, Westfall M, Townsend D, Blankenship M, Herron TJ, et al. (2008) Designing heart performance by gene transfer. Physiol Rev 4: 1567-1651.
30. Davis J, Wen H, Edwards T, Metzger JM (2008) Allele and species dependent contractile defects by restrictive and hypertrophic cardiomyopathy-linked troponin I mutants. J Mol Cell Cardiol 44: 891-904.
31. Michele DE, Albayya FP, Metzger JM (1999) Direct, convergent hypersensitivity of calcium-activated force generation produced by hypertrophic cardiomyopa-thy mutant alpha-tropomyosins in adult cardiac myocytes. Nat Med 5: 1413-1417.
32. Michele DE, Coutu P, Metzger JM (2002) Divergent abnormal muscle relaxation by hypertrophic cardiomyopathy and nemaline myopathy mutant tropomyosins. Physiol Genomics 9: 103-111.
33. Westfall MV, Rust EM, Albayya F, Metzger JM (1997) Adenovirus-mediated myofilament gene transfer into adult cardiac myocytes. Methods Cell Biol 52: 307-322.
34. Westfall MV, Rust EM, Metzger JM (1997) Slow skeletal troponin I gene transfer, expression, and myofilament incorporation enhances adult cardiac myocyte contractile function. Proc Natl Acad Sci U S A 94: 5444-5449.
35. Day S, Davis J, Westfall M, Metzger J (2006) Genetic engineering and therapy for inherited and acquired cardiomyopathies. Ann N Y Acad Sci 1080: 437-450.
36. Gomes AV, Potter JD (2004) Molecular and cellular aspects of troponin cardiomyopathies. Cardiac Engineering: from Genes and Cells to Structure and Function 1015: 214-224.
37. Gomes AV, Potter JD (2004) Cellular and molecular aspects of familial hypertrophic cardiomyopathy caused by mutations in the cardiac troponin I gene. Mol Cell Biochem 263: 99-114.
38. Metzger JM, Michele DE, Rust EM, Borton AR, Westfall MV (2003) Sarcomere thin filament regulatory isoforms. Evidence of a dominant effect of slow skeletal troponin I on cardiac contraction. J Biol Chem 278: 13118-13123.
39. Gordon AM, Homsher E, Regnier M (2000) Regulation of contraction in striated muscle. Physiol Rev 80: 853-924.
40. Moss RL (1992) Ca2+ regulation of mechanical properties of striated muscle. Mechanistic studies using extraction and replacement of regulatory proteins. Circ Res 70: 865-884.
41. Tobacman LS (1996) Thin filament-mediated regulation of cardiac contraction. Annu Rev Physiol 58: 447-481.
42. Zot AS, Potter JD (1989) Reciprocal coupling between troponin C and myosin crossbridge attachment. Biochemistry 28: 6751-6756.
43. Metzger JM (1995) Myosin binding-induced cooperative activation of the thin filament in cardiac myocytes and skeletal muscle fibers. Biophys J 68: 1430-1442.
44. Swartz DR, Moss RL (1992) Influence of a strong-binding myosin analogue on calcium-sensitive mechanical properties of skinned skeletal muscle fibers. J Biol Chem 267: 20497-20506.
45. Westfall MV, Borton AR, Albayya FP, Metzger JM (2002) Myofilament calcium sensitivity and cardiac disease: insights from troponin I isoforms and mutants. Circ Res 91: 525-531.
46. Coutu P, Metzger JM (2005) Genetic manipulation of calcium-handling proteins in cardiac myocytes. I. Experimental studies. Am J Physiol Heart Circ Physiol 288: H601-H612.
47. Michele DE, Albayya FP, Metzger JM (1999) Thin filament protein dynamics in fully differentiated adult cardiac myocytes: toward a model of sarcomere maintenance. J Cell Biol 145: 1483-1495.
48. Coutu P, Bennett CN, Favre EG, Day SM, Metzger JM (2004) Parvalbumin corrects slowed relaxation in adult cardiac myocytes expressing hypertrophic cardiomyopathy-linked alpha-tropomyosin mutations. Circ Res 94: 1235-1241.
49. Rust EM, Westfall MV, Metzger JM (1998) Stability of the contractile assembly and Ca2+-activated tension in adenovirus infected adult cardiac myocytes. Mol Cell Biochem 181: 143-155.
50. Herron TJ, Vandenboom R, Fomicheva E, Mundada L, Edwards T, et al. (2007) Calcium-independent negative inotropy by beta-myosin heavy chain gene transfer in cardiac myocytes. Circ Res 100: 1182-1190.
51. Day SM, Westfall MV, Fomicheva EV, Hoyer K, Yasuda S, et al. (2006) Histidine button engineered into cardiac troponin I protects the ischemic and failing heart. Nat Med 12: 181-189.
52. Lim CC, Yang H, Yang M, Wang CK, Shi J, et al. (2008) A novel mutant cardiac troponin C disrupts molecular motions critical for calcium binding affinity and cardiomyocyte contractility. Biophys J 94: 3577-3589.
53. Dweck D, Hus N, Potter JD (2008) Challenging current paradigms related to cardiomyopathies: Are changes in the Ca2+ sensitivity from myofilaments containing cardiac troponin C mutations (G159D and L29Q) good predictors of the phenotypic outcomes? J Biol Chem.
54. Biesiadecki BJ, Kobayashi T, Walker JS, John SR, de Tombe PP (2007) The troponin C G159D mutation blunts myofilament desensitization induced by troponin I Ser23/24 phosphorylation. Circ Res 100: 1486-1493.
55. Preston LC, Lipscomb S, Robinson P, Mogensen J, McKenna WJ, et al. (2007) Functional effects of the DCM mutant Gly159Asp Troponin C in skinned muscle fibres. Pflugers Arch 453: 771-776.
56. Marian AJ (2002) Modifier genes for hypertrophic cardiomyopathy. Curr Opin Cardiol 17: 242-252.
57. Semsarian C, Healey MJ, Fatkin D, Giewat M, Duffy C, et al. (2001) A polymorphic modifier gene alters the hypertrophic response in a murine model of familial hypertrophic cardiomyopathy. J Mol Cell Cardiol 33: 2055-2060.
58. Miller T, Szczesna D, Housmans PR, Zhao J, de Freitas F, et al. (2001) Abnormal contractile function in transgenic mice expressing a familial hypertrophic cardiomyopathy-linked troponin T (I79N) mutation. J Biol Chem 276: 3743-3755.
59. Blumenschein TM, Stone DB, Fletterick RJ, Mendelson RA, Sykes BD (2006) Dynamics of the C-terminal region of TnI in the troponin complex in solution. Biophys J 90: 2436-2444.
60. Lindhout DA, Boyko RF, Corson DC, Li MX, Sykes BD (2005) The role of electrostatics in the interaction of the inhibitory region of troponin I with troponin C. Biochemistry 44: 14750-14759.
61. Hilario E, da Silva SL, Ramos CH, Bertolini MC (2004) Effects of cardiomyopathic mutations on the biochemical and biophysical properties of the human alpha-tropomyosin. Eur J Biochem 271: 4132-4140.
62. Moss RL, Allen JD, Greaser ML (1986) Effects of partial extraction of troponin complex upon the tension-pCa relation in rabbit skeletal muscle. Further evidence that tension development involves cooperative effects within the thin filament. J Gen Physiol 87: 761-774.
63. Brandt PW, Diamond MS, Rutchik JS, Schachat FH (1987) Co-operative interactions between troponin-tropomyosin units extend the length of the thin filament in skeletal muscle. J Mol Biol 195: 885-896.
64. Brandt PW, Roemer D, Schachat FH (1990) Co-operative activation of skeletal muscle thin filaments by rigor crossbridges. The effect of troponin C extraction. J Mol Biol 212: 473-480.
65. Mehegan JP, Tobacman LS (1991) Cooperative interactions between troponin molecules bound to the cardiac thin filament. J Biol Chem 266: 966-972.
66. Martin AF (1981) Turnover of cardiac troponin subunits. Kinetic evidence for a precursor pool of troponin-I. J Biol Chem 256: 964-968.
67. Farah CS, Reinach FC (1995) The troponin complex and regulation of muscle contraction. FASEB J 9: 755-767.
68. Solaro RJ, Van Eyk J (1996) Altered interactions among thin filament proteins modulate cardiac function. J Mol Cell Cardiol 28: 217-230.
69. Westfall MV, Albayya FP, Turner II, Metzger JM (2000) Chimera analysis of troponin I domains that influence Ca(2+)-activated myofilament tension in adult cardiac myocytes. Circ Res 86: 470-477.
70. Tardiff JC (2005) Sarcomeric proteins and familial hypertrophic cardiomyopathy: linking mutations in structural proteins to complex cardiovascular phenotypes. Heart Fail Rev 10: 237-248.
71. Kim SJ, Iizuka K, Kelly RA, Geng YJ, Bishop SP, et al. (1999) An alpha-cardiac myosin heavy chain gene mutation impairs contraction and relaxation function of cardiac myocytes. Am J Physiol 276: H1780-H1787.
72. Palmer BM, Fishbaugher DE, Schmitt JP, Wang Y, Alpert NR, et al. (2004) Differential cross-bridge kinetics of FHC myosin mutations R403Q and R453C in heterozygous mouse myocardium. Am J Physiol Heart Circ Physiol 287: H91-H99.
73. Semsarian C, Ahmad I, Giewat M, Georgakopoulos D, Schmitt JP, et al. (2002) The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model. J Clin Invest 109: 1013-1020.
74. Eaton BL, Kominz DR, Eisenberg E (1975) Correlation between the inhibition of the acto-heavy meromyosin ATPase and the binding of tropomyosin to Factin: effects of Mg2+, KCl, troponin I, and troponin C. Biochemistry 14: 2718-2725.
75. Rajan S, Ahmed RP, Jagatheesan G, Petrashevskaya N, Boivin GP, et al. (2007) Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity. Circ Res 101: 205-214.
76. Tsoutsman T, Chung J, Doolan A, Nguyen L, Williams IA, et al. (2006) Molecular insights from a novel cardiac troponin I mouse model of familial hypertrophic cardiomyopathy. J Mol Cell Cardiol 41: 623-632.